Showing results (2171-2180 of 3,888) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|June 25, 2013
Monitor tumor burden with circulating tumor DNAWilliam D Figg, Jim Reid
Cancer Biology & Therapy|June 25, 2013
Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancerMhd Yaser Al-Marrawi, Bikramajit Singh Saroya, Matthew C Brennan, et al.
Cancer Biology & Therapy|June 25, 2013
Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cellsHaley L Peters, Ying Yan, Tara M Nordgren, et al.
Cancer Biology & Therapy|June 25, 2013
Dual kinin B1 and B2 receptor activation provides enhanced blood-brain barrier permeability and anticancer drug delivery into brain tumorsJérôme Côté, Martin Savard, Witold Neugebauer, et al.
Cancer Biology & Therapy|June 25, 2013
Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cellsNamita Chatterjee, Wei-Lin Winnie Wang, Tucker Conklin, et al.
Cancer Biology & Therapy|June 25, 2013
Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI ratsKristy Kutanzi, Olga Kovalchuk
Cancer Biology & Therapy|June 25, 2013
Identification of repurposed small molecule drugs for chordoma therapyMenghang Xia, Ruili Huang, Srilatha Sakamuru, et al.
Cancer Biology & Therapy|June 14, 2013
Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabineDapeng Xu, Michael G Cobb, Lily Gavilano, et al.
Cancer Biology & Therapy|May 3, 2012
The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinomaAdam Gastonguay, Tracy Berg, Andrew D Hauser, et al.
Cancer Biology & Therapy|October 9, 2013
A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumorsHaibiao Gong, Joy L Kovar, Lael Cheung, et al.
Pageof 389